These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


104 related items for PubMed ID: 4348147

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Homogeneously staining regions (HSR) in a human malignant melanoma.
    Brieux de Salum S, Slavutsky I, Besuschio S, Pavlovsky AA.
    Cancer Genet Cytogenet; 1984 Jan; 11(1):53-60. PubMed ID: 6690023
    [Abstract] [Full Text] [Related]

  • 3. Examination of clonal variants from human malignant melanoma studied by chromosome banding analysis.
    Bridge J, Leong SP, Burgess AC, Thompson F, Trent JM.
    Melanoma Res; 1991 Jan; 1(4):289-96. PubMed ID: 1823635
    [Abstract] [Full Text] [Related]

  • 4. Cytogenetics of cutaneous malignant melanoma.
    Thompson CT.
    Pathology (Phila); 1994 Jan; 2(2):401-12. PubMed ID: 9420910
    [Abstract] [Full Text] [Related]

  • 5. Molecular cytogenetic characterization of a novel cell line established from a superficial spreading melanoma.
    Treszl A, Ladanyi A, Rakosy Z, Buczko Z, Adany R, Balazs M.
    Front Biosci; 2006 May 01; 11():1844-53. PubMed ID: 16368560
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas.
    Richmond A, Fine R, Murray D, Lawson DH, Priest JH.
    J Invest Dermatol; 1986 Mar 01; 86(3):295-302. PubMed ID: 3745955
    [Abstract] [Full Text] [Related]

  • 8. Multiple karyotypic abnormalities, including structural rearrangements of 11p, in cell lines from malignant melanomas.
    Heim S, Mandahl N, Arheden K, Giovanella BC, Yim SO, Stehlin JS, Mitelman F.
    Cancer Genet Cytogenet; 1988 Oct 01; 35(1):5-20. PubMed ID: 3180009
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
    Bani MR, Rak J, Adachi D, Wiltshire R, Trent JM, Kerbel RS, Ben-David Y.
    Cancer Res; 1996 Jul 01; 56(13):3075-86. PubMed ID: 8674065
    [Abstract] [Full Text] [Related]

  • 11. Quantitative estimation of chromosome aberration frequency in cancer patients induced by endogenous and exogenous factors.
    Chebotarev AN, Kirichenko OP, Sokolova OI.
    Bull Exp Biol Med; 2000 Nov 01; 130(11):1106-8. PubMed ID: 11182829
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Establishment of a novel Chinese metastatic melanoma cell line showing the new cytogenetic and biological properties.
    Yi X, Zhu G, Li Y, Liu Y, Luan Q, Dai W, Wang L, Liao W, Gao T, Li C.
    Cell Biol Int; 2015 Apr 01; 39(4):508-14. PubMed ID: 25639772
    [Abstract] [Full Text] [Related]

  • 14. Tumor cell karyotypes in malignant melanoma.
    Henry WM, Didolkar MS, Lopez R, Tomei LD.
    J Surg Oncol; 1979 Apr 01; 11(1):31-8. PubMed ID: 431080
    [Abstract] [Full Text] [Related]

  • 15. Cytogenetic analysis of melanoma cell lines: subclone selection in long-term melanoma cell cultures.
    Lotem M, Yehuda-Gafni O, Butnaryu E, Drize O, Peretz T, Abeliovich D.
    Cancer Genet Cytogenet; 2003 Apr 15; 142(2):87-91. PubMed ID: 12699882
    [Abstract] [Full Text] [Related]

  • 16. Chromosome alterations in human malignant melanoma.
    Trent JM, Leong SP, Meyskens FL.
    Carcinog Compr Surv; 1989 Apr 15; 11():165-86. PubMed ID: 2646015
    [Abstract] [Full Text] [Related]

  • 17. Increased spontaneous mutation rates and prevalence of karyotype abnormalities in highly metastatic human melanoma cell lines.
    Bailly M, Bertrand S, Doré JF.
    Melanoma Res; 1993 Feb 15; 3(1):51-61. PubMed ID: 8471837
    [Abstract] [Full Text] [Related]

  • 18. Primary melanoma cells of the vertical growth phase: similarities to metastatic cells.
    Herlyn M, Balaban G, Bennicelli J, Guerry D, Halaban R, Herlyn D, Elder DE, Maul GG, Steplewski Z, Nowell PC.
    J Natl Cancer Inst; 1985 Feb 15; 74(2):283-9. PubMed ID: 3856042
    [Abstract] [Full Text] [Related]

  • 19. Transdifferentiation of Melanoma Cells by the Reprogramming Factors Attenuates Malignant Nature In Vitro and In Vivo.
    Takaishi M, Sano S.
    J Invest Dermatol; 2019 Jan 15; 139(1):254-257. PubMed ID: 29990471
    [No Abstract] [Full Text] [Related]

  • 20. Multiple cytogenetic clones in a basal cell carcinoma.
    Kawasaki RS, Caldeira LF, André FS, Gasques JA, Castilho WH, Bozola AR, Thomé JA, Tajara EH.
    Cancer Genet Cytogenet; 1991 Jul 01; 54(1):33-8. PubMed ID: 2065314
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.